Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EternaTear
AddedFeb 16, 2024
UpdatedJun 18, 2026
EternaTear

EternaTear

Series A

EternaTear: Innovating next-gen dry eye therapy for the over-the-counter market.

HQ
Raleigh, NC, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

EternaTear was founded with the mission to revolutionize the treatment of dry eye by developing next-generation, over-the-counter artificial tear solutions. The company focuses on providing longer-lasting relief for individuals suffering from dry eye, a condition characterized by itching, burning, and pain due to the inability of the tear film and lids to protect the eye surface. EternaTear aims to address the diverse underlying causes of dry eye, which can lead to significant discomfort and potential corneal damage if untreated.

Notable figures affiliated with EternaTear include leading experts in ophthalmology and pharmaceutical development, although specific names are not provided. The company has garnered attention from key investors interested in innovative healthcare solutions. EternaTear's primary achievement lies in its development of a more effective artificial tear product that promises to enhance the quality of life for dry eye sufferers. Their impact is marked by the potential to set new standards in dry eye treatment within the over-the-counter market.

EternaTear - Similar Companies

TearSolutions logo

TearSolutions

tearsolutions.com

TearClear logo

TearClear

tearclear.com

Eyetamins logo

Eyetamins

eyetamins.co

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Surface Ophthalmics logo

Surface Ophthalmics

OcuTerra Therapeutics logo

OcuTerra Therapeutics

ocuterratx.com

EyeCyte logo

EyeCyte

eyecyte.com

Ocular Science logo

Ocular Science

ocularscience.com

Eyebot logo

Eyebot

eyebot.tech

EyeScience Labs logo

EyeScience Labs

Vitranu logo

Vitranu

vitranu.com

Visus Therapeutics logo

Visus Therapeutics

visustx.com

Ocular Therapeutix logo

Ocular Therapeutix

ocutx.com

Forsight Labs logo

Forsight Labs

Visant Medical logo

Visant Medical

EternaTear - Quick Facts

Who are EternaTear's competitors?

Companies similar to EternaTear include TearSolutions, TearClear, Eyetamins and Surface Pharmaceuticals.

When was EternaTear founded?

EternaTear was founded in 2018.

Where is EternaTear's headquarters located?

EternaTear's headquarters is located in Raleigh, NC, US.

When was EternaTear's last funding round?

EternaTear's most recent funding round was for $4.9M (USD) in October 2020.

How much has EternaTear raised to-date?

As of Oct 11, 2020, EternaTear has raised a total of $4.9M (USD).

How many employees does EternaTear have?

EternaTear has 5 employees as of Feb 5, 2024.

EternaTear - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Artificial Tears
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified